Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GSK3B | P49841 | 20/20 | 0.65 |
| ▸ | GSK3A | P49840 | 14/20 | 0.65 |
| ▸ | PRKCB | P05771 | 6/20 | 0.65 |
| ▸ | CDK4 | P11802 | 6/20 | 0.65 |
| ▸ | CDK2 | P24941 | 5/20 | 0.65 |
| ▸ | CDK5 | Q00535 | 3/20 | 0.65 |
| ▸ | PDK1 | Q15118 | 3/20 | 0.65 |
| ▸ | CAMK2G | Q13555 | 3/20 | 0.65 |
| ▸ | CAMK2D | Q13557 | 3/20 | 0.65 |
| ▸ | PRKCG | P05129 | 2/20 | 0.65 |
| ▸ | LCK | P06239 | 2/20 | 0.65 |
| ▸ | CDK1 | P06493 | 2/20 | 0.65 |
| ▸ | PIM1 | P11309 | 2/20 | 0.65 |
| ▸ | CLK2 | P49760 | 2/20 | 0.65 |
| ▸ | RPS6KA3 | P51812 | 2/20 | 0.65 |
| ▸ | PRKCD | Q05655 | 2/20 | 0.65 |
| ▸ | DYRK1A | Q13627 | 2/20 | 0.65 |
| ▸ | PKN2 | Q16513 | 2/20 | 0.65 |
| ▸ | SLK | Q9H2G2 | 2/20 | 0.65 |
| ▸ | CLK4 | Q9HAZ1 | 2/20 | 0.65 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ly-2090314 SCHEMBL29533963 | 0.79 | GSK3B (1.00) | GSK3BGSK3APRKCBCDK4CDK2 | |
| Ly-2090314 SCHEMBL633455 | 0.79 | GSK3B (1.00) | GSK3BGSK3APRKCBCDK4CDK2 | |
| Ly-2090314 SCHEMBL635424 | 0.79 | GSK3B (0.98) | GSK3BGSK3APRKCBCDK4CDK2 | |
| SCHEMBL25667208 | 0.77 | GSK3B (0.82) | GSK3BGSK3APRKCBCDK4CDK2 | |
| SCHEMBL22510676 | 0.77 | GSK3B (0.74) | GSK3BGSK3APRKCBCDK4CDK2 | |
| SCHEMBL22510649 | 0.77 | GSK3B (0.74) | GSK3BGSK3APRKCBCDK4CDK2 | |
| Ly-2090314 SCHEMBL633612 | 0.76 | GSK3B (0.93) | GSK3BGSK3APRKCBCDK4CDK2 | |
| SCHEMBL20439052 | 0.76 | GSK3B (0.80) | GSK3BGSK3APRKCBCDK4CDK2 | |
| SCHEMBL20439145 | 0.76 | GSK3B (0.80) | GSK3BGSK3APRKCBCDK4CDK2 | |
| Ly-2090314 SCHEMBL633866 | 0.76 | GSK3B (0.92) | GSK3BGSK3APRKCBCDK4CDK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220186183-A1 | NOVEL GLIA-LIKE CELLS DIFFERENATIATED FROM SOMATIC CELLS, PREPARATION METHOD THEREFOR, COCKTAIL COMPOSITION FOR PREPARING SAME, CELL THERAPEUTIC AGENT FOR PREVENTING OR TREATING NEUROLOGICAL DISORDERS, COMPRISING SAME, AND METHOD FOR PREVENTING AND TREATING NEUROLOGICAL DISORDERS BY ADMINISTERING SAME | Cellapeutics Bio (KR) | 2022-06-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220186183-A1 | NOVEL GLIA-LIKE CELLS DIFFERENATIATED FROM SOMATIC CELLS, PREPARATION METHOD THEREFOR, COCKTAIL COMPOSITION FOR PREPARING SAME, CELL THERAPEUTIC AGENT FOR PREVENTING OR TREATING NEUROLOGICAL DISORDERS, COMPRISING SAME, AND METHOD FOR PREVENTING AND TREATING NEUROLOGICAL DISORDERS BY ADMINISTERING SAME | GMFG, HGF, BDNF | GSK3B 293/4885GSK3A 320/4885PRKCB 901/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.